Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson's Disease.

Front Genet · 2019 · PMC6532453 · PMID 31156712

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Among them only age at diagnosis, time from diagnosis to initiation of levodopa treatment, and DRD3 rs6280 were previously identified as significant or nominally significant predictors by univariate analysis.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.